
COBRE Center: Pioneering research on genetic and neural basis of attention, decision making, and action.
The COBRE Center for Central Nervous System Function focuses on pioneering research into the genetic and neural basis of attention, decision making, and action. The center investigates how brain networks, primarily in the neocortex and modulated by sub-cortical processing, mediate these essential functions. Their research aims to understand behavioral and brain mechanisms of attention, including vigilance, orienting, and perceptual and action selection.
Key achievements include significant contributions to understanding high-level brain functions and their underlying neural mechanisms. The center's work has had a substantial impact on the field of neuroscience, advancing knowledge in brain function and behavior. Notable affiliated researchers and collaborations have furthered the center's mission, making it a leading institution in brain function research.

Neuroscape

Sanders-Brown Center on Aging
medicine.uky.edu

Cerebrum Health Centers
cerebrum.com

Center for Vital Longevity

Ontario Brain Institute
braininstitute.ca

The Stark Neurosciences Research Institute
medicine.iu.edu

CanLab

Tulane University Brain Institute
brain.tulane.edu

Neuronity
neuronitytx.com

C8 Sciences
c8sciences.com

Neurolink
Neuro3 Therapeutics

Cerevance
cerevance.com

Cerebral Therapeutics

NeuroCog Trials
Companies similar to Cobre Center for Central Nervous System Function include Neuroscape, Sanders-Brown Center on Aging, Cerebrum Health Centers and Center for Vital Longevity.
Cobre Center for Central Nervous System Function was founded in 2018.
Cobre Center for Central Nervous System Function's headquarters is located in Providence, RI, US.
Cobre Center for Central Nervous System Function's most recent funding round was for $12M (USD) in December 2018.
As of Dec 3, 2018, Cobre Center for Central Nervous System Function has raised a total of $12M (USD).
Cobre Center for Central Nervous System Function has 3,000 employees as of Feb 4, 2024.